Skip links

2026 Marketing Study – How Top Multi-Location & Health Systems are Growing

Author: Bill Ross | Published: July 21, 2026 | Updated: July 21, 2026

Students Collaborative Study Session Neon Ring Cyan Emulent
The fastest growing multi-location and health system brands in 2026 fund the location layer first: reviews, profiles, self-scheduling, and price clarity at every individual site, before a dollar goes to system-level awareness. That order matters because patients no longer choose a system. They choose a location, and they choose it during twenty minutes of research your brand campaign never touches. The margin math leaves no room to get this wrong. Kaufman Hall’s National Hospital Flash Report, drawing on more than 1,300 U.S. hospitals, put the median hospital operating margin at 1.3% for calendar year 2025, with an eroding payer mix and rising bad debt underneath it. At a 1.3% margin, a marketing budget that buys impressions instead of booked appointments is not a strategy. It is a leak.

We studied what the growth leaders in multi-location healthcare actually do differently, and we checked every claim against primary research published since 2020: KFF, Pew Research Center, Experian Health, EMARKETER, Gallup, and Kaufman Hall. The pattern that emerged is not a secret channel or a clever campaign. It is a spending order. The winners treat each location’s digital front door as the product, and they buy media only after that product converts.

Patients Research the Location, Not the System

Your system brand gets patients to consider you. Your location’s review profile decides whether they book. In rater8’s national patient survey, fielded in December 2024 across more than 1,000 U.S. patients, 84% said they check online reviews before choosing a new provider, 51% read at least six reviews before deciding, and 40% had canceled an appointment or reconsidered a provider because of what they read. The number that should reorder budgets is this one: 61% said negative reviews would override a personal recommendation. A friend’s referral, the channel health systems have counted on for decades, now loses to a page of strangers.

Bar Chart: 84% Of U.s. Patients Check Online Reviews Before Choosing A Provider, 61% Say Negative Reviews Override Personal Recommendations, 51% Read At Least Six Reviews, And 40% Have Canceled Or Reconsidered Over Reviews, Per Rater8'S December 2024 Survey.

The mechanism is social proof operating exactly where it is strongest. Healthcare purchases combine high stakes with unverifiable expertise: a patient cannot audit a surgeon’s skill, so they audit the aggregate experience of people who came before them. Sixty strangers agreeing feels safer than one brother-in-law’s opinion, and the feeling is rational. This is survey data, self-reported rather than platform-measured, so treat the exact figures as directional. The direction is hard to argue with, and a second survey confirms it: Tebra’s sixth annual Patient Perspectives report, fielded in June 2025 across 3,964 U.S. adults, found 79% read reviews before choosing a provider and 69% call positive reviews very or extremely important to the decision.

Here is the position the incumbent advice on page one refuses to take: for a multi-location brand, review velocity per location is a better growth predictor than any system-level awareness metric, and it deserves the budget line awareness currently holds. A system with a strong name and a three-star location loses that market. A system nobody has heard of with a 4.8 across 400 reviews at the local site wins it. If your locations average fewer than a handful of new reviews a month, fix the ask-and-respond process before you approve another media plan. Our hospitals growth study found the same split a year ago, and the gap has only widened since.

“When a health system shows us a brand tracker before it shows us review counts by location, we already know where the growth went. It went to the competitor who answered 200 patient reviews while this system was fielding an awareness survey.” – The Strategy Team at Emulent

AI Became the Second Front Door, and It Reads Your Reviews

Monthly use of AI chatbots for health information nearly doubled in two years, from 17% of U.S. adults in June 2024 to 29% in 2026, per the KFF Tracking Poll on Health Information and Trust. A separate KFF wave, fielded in early 2026, found 32% of adults used AI for health information in the past year, on par with social media. Gallup and West Health put past-use at 25% of U.S. adults, roughly 66 million people, most of them using AI before or after a doctor visit rather than instead of one.

Line Chart: Monthly Ai Health Information Use Among U.s. Adults Rose From 17% In June 2024 To 29% In 2026 Per Kff, Projected By Emulent To 36% In 2027 And 41% In 2028 Using An S-Curve Adoption Model With A Trust-Threshold Ceiling Near 50%.

Projection: Emulent analysis based on S-curve adoption governed by a trust threshold, assuming a ceiling near 50% of adults because 77% report privacy concerns about health data in AI tools (KFF, 2026) and only 18% of users rate chatbot answers as highly accurate, cross-checked against Pew Research Center’s October 2025 finding that just 7% of adults use AI for health information often.

We project the monthly-use curve reaches roughly 41% by 2028 and then bends hard, because trust moves slower than tools. Pew’s October 2025 survey of 5,111 adults is the honest brake on the hype: only 7% use AI chatbots for health information often, users rate the answers convenient rather than accurate, and 85% of Americans still get health information from their providers. AI is not replacing the doctor. It is replacing the first Google search, which is exactly where a new patient used to meet your brand.

What decides whether AI recommends your location? Largely the same public evidence that decides the review battle: profile data, review volume and sentiment, and consistent location information across the web. We have written before about how reviews affect AI search, and the house line holds: you cannot buy your way into an AI answer, you can only earn your way in with structured, verifiable proof at the location level. That is why we build search everywhere optimization around location evidence rather than system messaging. The systems treating AI visibility as a PR problem are solving the wrong equation.

“Patients ask ChatGPT the question they used to ask Google, and ChatGPT answers with whatever public evidence exists about your locations. Marketing built on claims is invisible to that process. Marketing built on proof compounds in it. Buyers act on what feels verifiable, and machines now quote the same signals.” – Bill Ross, Founder of Emulent

The Scheduling Gap Is the Cheapest Growth Lever in Healthcare

Eighty percent of patients want to schedule appointments from their phone, and only 54% of providers offer self-scheduling. That gap comes straight from Experian Health’s 2025 State of Patient Access Survey, which also found 71% of providers calling scheduling improvement an urgent priority and another 10% planning to add self-scheduling within six months. Read that as a market signal: your fastest-growing competitor is closing this gap right now, and every location without online booking is paying for clicks that end at a phone tree.

Chart: 80% Of Patients Want Mobile Scheduling But Only 54% Of Providers Offered Self-Scheduling In 2025 Per Experian Health, Projected By Emulent To 63% In 2026, 70% In 2027, And 74% In 2028 With An Adoption Ceiling Near The 80% Demand Line.

Projection: Emulent analysis based on a social proof cascade, since holdout practices visibly lose bookings once market leaders offer self-scheduling, assuming a ceiling near the 80% demand line rather than 100% because status quo bias and EHR switching costs keep a tail of practices out, cross-checked against Experian Health’s own 2025 finding that 10% more providers planned to add self-scheduling within six months.

For a multi-location brand, this is a conversion problem wearing an IT costume. Every acquisition dollar you spend flows toward a booking moment, and the booking moment is where healthcare leaks. The psychology is plain: a patient researching at 9 pm is at peak intent, and intent decays by morning. A “call during business hours” instruction converts that intent into a to-do item, and to-do items die. The growth leaders in our data put self-scheduling on every location page and every profile before scaling paid media, because a 20% lift in booking completion beats a 20% lift in traffic at a fraction of the cost. If you run the numbers on your own funnel, we expect you will cancel at least one campaign and reassign the money. That is the correct outcome, even when the campaign is ours to lose.

Price Clarity Is Now an Acquisition Strategy, Not a Compliance Chore

The share of patients receiving a cost estimate before care rose from 29% in 2022 to 41% in 2025, per Experian Health’s survey series, and the systems treating estimates as marketing rather than paperwork are taking patients from the ones that don’t. The behavioral driver is loss aversion: a surprise bill is a loss, and people work harder to avoid losses than to gain equivalent benefits. Experian Health’s 2026 edition quantifies the stakes: 73% of providers say patients at least occasionally delay or forfeit care when they cannot get an estimate. Care that never happens is revenue that never happens, and it usually happens later at the competitor who quoted a price.

Line Chart: Patients Receiving A Cost Estimate Before Care Rose From 29% In 2022 To 41% In 2025 Per Experian Health, Projected By Emulent To 45% In 2026, 49% In 2027, And 52% In 2028 With A Structural Ceiling Near 65% Of Quotable Encounters.

Projection: Emulent analysis based on loss aversion driving patient demand for pre-care estimates, assuming a structural ceiling near 65% because payer variability and prior authorization keep roughly a third of encounters unquotable, cross-checked against Experian Health’s 2026 finding that 73% of providers report patients delaying or forfeiting care without an estimate.

We project estimate delivery reaches about 52% of patients by 2028 and stalls near a 65% structural ceiling, because a third of encounters simply cannot be quoted in advance under current payer rules. The marketing implication does not wait for the ceiling: publish real prices for your quotable services now. Urgent care visits, imaging, physicals, common procedures. The location that answers “what will this cost me” on the page wins the patient who was about to bounce to the one that does. Vague “contact us for pricing” language reads as a warning label to a loss-averse buyer.

The Perception Gap: Systems Grade Inputs, Patients Grade the Front Door

Nearly half of providers, 46%, believe patient access got better over the past year. Only 18% of patients agree. Experian Health’s 2026 survey caught this 28-point perception gap in the act, up from a 36% versus 16% split in 2025. The gap is what happens when leadership scores itself on tool rollouts and portal launches while patients score the only thing they can see: whether booking, prices, and answers actually got easier at their location. Access to a practitioner remained the top patient complaint for the fourth straight year in the same survey.

Bar Chart: 46% Of Providers Say Patient Access Improved Versus 18% Of Patients, A 28-Point Perception Gap, Per Experian Health'S 2026 State Of Patient Access Survey.

This gap is the strongest objection to our stance, so let’s meet it head on. A skeptic could say the location layer is already funded, since systems are visibly investing in digital tools, and the next dollar should go to awareness. The 28-point gap says the opposite: the tools exist and the experience still fails, which means the investment stopped at procurement and never reached the patient. Buying scheduling software for the system is an input. A working “book now” button on the Maple Street location’s profile at 9 pm is an outcome. Fastest-growing brands audit outcomes location by location, mystery-shopping their own front doors quarterly. Most systems have never once booked an appointment through their own weakest location’s profile. Start there, and the local medical practice marketing trends data suggests you will find the gap within an hour.

Where the Ad Dollars Are Going, and Why More Spend Is Not the Answer

U.S. healthcare and pharma digital ad spending hit $24.77 billion in 2025, up 13.3% year over year, and EMARKETER forecasts $26.2 billion for 2026, nearly triple the $9.53 billion spent in 2020. Digital’s share of healthcare ad budgets climbs from 76% toward a forecast 82% by 2027, per EMARKETER’s healthcare ad spending forecast. Every one of those dollars competes in the same auctions your locations bid in. Rising category spend with a fixed supply of patient attention means one thing: higher costs per click, every year, forever.

Bar Chart: U.s. Healthcare And Pharma Digital Ad Spend Grew From $9.53 Billion In 2020 To $24.77 Billion In 2025, With Emarketer Forecasting $26.2 Billion In 2026, Projected By Emulent To Reach Roughly $29.7 Billion In 2028 As Growth Decelerates Toward A Mid-Single-Digit Rate.

Projection: Emulent analysis based on habituation and auction inflation decelerating growth from 13% toward mid-single digits, assuming digital’s share of healthcare ad budgets bends toward an 85% ceiling as loss-averse incumbents defend their remaining TV spend, cross-checked against EMARKETER’s forecast of an 82% digital share by 2027.

This chart is why the spending order in our stance is not a preference. It is arithmetic. In an inflating auction, the brand whose location pages convert at twice the rate pays half the effective acquisition cost, at any budget level. Media buys rent attention at rising rates. Reviews, profiles, scheduling, and price clarity are owned conversion assets that make every rented click worth more, and their value compounds while media costs inflate. Spend on the auction before the asset and you are financing your competitors’ benchmark data. Our healthcare marketing industry projections track the same deceleration from the budget side.

The 2026 Playbook: Centralize the Brand System, Localize the Proof

The operating model behind every fast grower we studied splits cleanly in two. The brand is built once, as a system: positioning, identity, photography, messaging architecture, held to standard by a central team, which is the work of a brand strategy agency engagement done properly rather than a logo project. The proof is built everywhere, locally: each location owns its reviews, its photos of real staff, its accurate hours and services, its booking link, its published prices. Systems fail in both directions. Some centralize everything and produce 40 identical, evidence-free location pages. Others localize everything and produce 40 different brands. The winners standardize the promise and localize the evidence for it, which is what healthcare branding means when it is treated as a system rather than a deliverable.

On the visibility side, the work is unglamorous and decisive. Local SEO ranking factors reward exactly what patients reward: complete profiles, review volume and recency, response behavior, and consistent data. Run every location through the 20 point local SEO checklist before any campaign launches, and budget the program honestly. We published our math on local SEO pricing for multi location brands, and the short version is that per-location costs drop with scale while per-location attention cannot, so staff for the attention. For health systems in particular, healthcare local SEO carries compliance constraints that generic local programs miss, physician name formats, department versus practitioner listings, and review responses that never confirm a care relationship.

And one piece of advice that costs us money to give: if your locations average under 20 reviews, lack self-scheduling, and publish no prices, do not hire a healthcare marketing agency for a paid media engagement yet. Fix the front door first, with or without us. Media poured into a leaking funnel produces the one thing worse than no data: confident conclusions from a broken test.

“Half the multi-location budgets we audit spend 80% on media and 20% on the pages and profiles that media lands on. Flip that ratio for two quarters. The brands that do never flip it back, because cost per booked appointment drops enough that the media budget funds itself.” – The Strategy Team at Emulent

What This Means for Your 2026 Budget

The stance we opened with survives contact with every dataset in this study: fund the location layer first. Reviews outrank referrals, so review operations outrank awareness. AI answers are assembled from location evidence, so evidence outranks messaging. Intent dies at phone trees, so scheduling outranks traffic. Surprise bills repel loss-averse buyers, so published prices outrank brand promises. And a $26 billion auction guarantees that conversion assets outrank media volume on any time horizon past one quarter.

The sequence for a multi-location or health system brand in 2026 is short. Audit every location’s front door as a patient would, at 9 pm, on a phone. Close the review, scheduling, and pricing gaps at the weakest locations first, because system reputation is set by the worst location a patient meets, not the average. Then, and only then, scale media into a funnel that converts. The systems that run this order are growing at margins the industry says are impossible. The ones that run it backward are buying impressions with a 1.3% margin. Growth in this industry is no longer decided by who spends the most. It is decided by who deserves the booking at the moment a specific patient researches a specific location, and that is a fight you win location by location, or not at all.